In this pilot study, we compared the NEB-1 cell line, derived from a healthy donor, and the KEB-7 cell line, derived from a patient affected by severe EBS carrying the mutation KRT14 R125P [49]. Here, KRT14 is linked to epidermolysis bullosa simplex.